PTC Therapeutics
PTCTPTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.In September 2009, PTC entered into an agreement with R …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at PTC Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/3/2025 | Sell | Reeve, Emma | Director | $78.6 | $57,628 |
| 12/2/2025 | Sell | Klein, Matthew B. | CHIEF EXECUTIVE OFFICER | $79.1 | $271,052 |
| 11/25/2025 | Sell | Almstead, Neil Gregory | CHIEF TECHNICAL OPS OFFICER | $83.9 | $6,001,934 |
| 11/25/2025 | Sell | Jacobson, Allan Steven | Director | $84.0 | $1,186,282 |
| 11/24/2025 | Sell | Almstead, Neil Gregory | CHIEF TECHNICAL OPS OFFICER | $80.2 | $2,852,030 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)